Purple Biotech (PPBT) Enterprise Value (2017 - 2021)

Purple Biotech (PPBT) has disclosed Enterprise Value for 5 consecutive years, with -$47.2 million as the latest value for Q4 2021.

  • On a quarterly basis, Enterprise Value rose 18.35% to -$47.2 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$47.2 million, a 18.35% increase, with the full-year FY2021 number at -$47.2 million, up 18.35% from a year prior.
  • Enterprise Value was -$47.2 million for Q4 2021 at Purple Biotech, up from -$57.8 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$4.4 million in Q4 2019 to a low of -$57.8 million in Q4 2020.
  • A 5-year average of -$24.7 million and a median of -$7.4 million in 2017 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: skyrocketed 34.25% in 2019, then plummeted 1215.24% in 2020.
  • Purple Biotech's Enterprise Value stood at -$7.4 million in 2017, then increased by 10.1% to -$6.7 million in 2018, then surged by 34.25% to -$4.4 million in 2019, then tumbled by 1215.24% to -$57.8 million in 2020, then grew by 18.35% to -$47.2 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Enterprise Value are -$47.2 million (Q4 2021), -$57.8 million (Q4 2020), and -$4.4 million (Q4 2019).